Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-12T00:15:46.919Z.
Calculation as of: 2026-09-12T00:15:46.919Z.
Quote observation: 2026-09-11T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 21d4530f46c27a330a27e13acc83cdd67f4baeb56c07e52c66d3cc6e0046e444
PEG RATIO
N/A
Labcorp Holdings Inc.
Market Cap
$25.55B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | N/A |
| Incyte Corporation (INCY)vs › | $24.62B | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | N/A |
| BioNTech SE (BNTX)vs › | $24.30B | N/A |
| Medline Inc. (MDLN)vs › | $27.51B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | N/A |
| Waters Corporation (WAT)vs › | $30.54B | N/A |
PEG Ratio
N/A
P/E Ratio
25.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
